Global Filgrastim Injection Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Filgrastim Injection is used to decrease the chance of infection in people who have non myeloid cancer (cancer that does not involve the bone marrow) and are receiving chemotherapy medications that may decrease the number of neutrophils (a type of blood cell needed to fight infection). Filgrastim injection is also used to help increase the number of white blood cells, and decrease the length of time with fever in people with acute myeloid leukemia (AML; a type of cancer of the white blood cells) who are receiving treatment with chemotherapy medications. Filgrastim injection is also used in people who are undergoing bone marrow transplants, in people who have severe chronic neutropenia (condition in which there are a low number of neutrophils in the blood), and to prepare the blood for leukapheresis (a treatment in which certain blood cells are removed from the body. Filgrastim injection is also used to increase the chance of survival in people who have been exposed to harmful amounts of radiation, which can cause severe and life-threatening damage to the bone marrow. Filgrastim is in a class of medications called colony-stimulating factors. It works by helping the body make more neutrophils.
LPI (LP Information)' newest research report, the “Filgrastim Injection Industry Forecast” looks at past sales and reviews total world Filgrastim Injection sales in 2022, providing a comprehensive analysis by region and market sector of projected Filgrastim Injection sales for 2023 through 2029. With Filgrastim Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Filgrastim Injection industry.
This Insight Report provides a comprehensive analysis of the global Filgrastim Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Filgrastim Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Filgrastim Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Filgrastim Injection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Filgrastim Injection.
The global Filgrastim Injection market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Filgrastim Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Filgrastim Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Filgrastim Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Filgrastim Injection players cover Accord Healthcare, Teva Pharmaceuticals, Pfizer, Amgen Inc and Novartis AG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Filgrastim Injection market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Filgrastim Injection market?
What factors are driving Filgrastim Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Filgrastim Injection market opportunities vary by end market size?
How does Filgrastim Injection break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Filgrastim Injection is used to decrease the chance of infection in people who have non myeloid cancer (cancer that does not involve the bone marrow) and are receiving chemotherapy medications that may decrease the number of neutrophils (a type of blood cell needed to fight infection). Filgrastim injection is also used to help increase the number of white blood cells, and decrease the length of time with fever in people with acute myeloid leukemia (AML; a type of cancer of the white blood cells) who are receiving treatment with chemotherapy medications. Filgrastim injection is also used in people who are undergoing bone marrow transplants, in people who have severe chronic neutropenia (condition in which there are a low number of neutrophils in the blood), and to prepare the blood for leukapheresis (a treatment in which certain blood cells are removed from the body. Filgrastim injection is also used to increase the chance of survival in people who have been exposed to harmful amounts of radiation, which can cause severe and life-threatening damage to the bone marrow. Filgrastim is in a class of medications called colony-stimulating factors. It works by helping the body make more neutrophils.
LPI (LP Information)' newest research report, the “Filgrastim Injection Industry Forecast” looks at past sales and reviews total world Filgrastim Injection sales in 2022, providing a comprehensive analysis by region and market sector of projected Filgrastim Injection sales for 2023 through 2029. With Filgrastim Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Filgrastim Injection industry.
This Insight Report provides a comprehensive analysis of the global Filgrastim Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Filgrastim Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Filgrastim Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Filgrastim Injection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Filgrastim Injection.
The global Filgrastim Injection market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Filgrastim Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Filgrastim Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Filgrastim Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Filgrastim Injection players cover Accord Healthcare, Teva Pharmaceuticals, Pfizer, Amgen Inc and Novartis AG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Filgrastim Injection market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- 300mcg/mL (vial)
- 480mcg/1.6 mL (vial)
- 300mcg/0.5mL (Prefilled Syringe)
- 480mcg/0.8mL (Prefilled Syringe)
- Adult Use
- Pediatric Use
- Geriatric Use
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Accord Healthcare
- Teva Pharmaceuticals
- Pfizer
- Amgen Inc
- Novartis AG
What is the 10-year outlook for the global Filgrastim Injection market?
What factors are driving Filgrastim Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Filgrastim Injection market opportunities vary by end market size?
How does Filgrastim Injection break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Filgrastim Injection Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Filgrastim Injection by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Filgrastim Injection by Country/Region, 2018, 2022 & 2029
2.2 Filgrastim Injection Segment by Type
2.2.1 300mcg/mL (vial)
2.2.2 480mcg/1.6 mL (vial)
2.2.3 300mcg/0.5mL (Prefilled Syringe)
2.2.4 480mcg/0.8mL (Prefilled Syringe)
2.3 Filgrastim Injection Sales by Type
2.3.1 Global Filgrastim Injection Sales Market Share by Type (2018-2023)
2.3.2 Global Filgrastim Injection Revenue and Market Share by Type (2018-2023)
2.3.3 Global Filgrastim Injection Sale Price by Type (2018-2023)
2.4 Filgrastim Injection Segment by Application
2.4.1 Adult Use
2.4.2 Pediatric Use
2.4.3 Geriatric Use
2.5 Filgrastim Injection Sales by Application
2.5.1 Global Filgrastim Injection Sale Market Share by Application (2018-2023)
2.5.2 Global Filgrastim Injection Revenue and Market Share by Application (2018-2023)
2.5.3 Global Filgrastim Injection Sale Price by Application (2018-2023)
3 GLOBAL FILGRASTIM INJECTION BY COMPANY
3.1 Global Filgrastim Injection Breakdown Data by Company
3.1.1 Global Filgrastim Injection Annual Sales by Company (2018-2023)
3.1.2 Global Filgrastim Injection Sales Market Share by Company (2018-2023)
3.2 Global Filgrastim Injection Annual Revenue by Company (2018-2023)
3.2.1 Global Filgrastim Injection Revenue by Company (2018-2023)
3.2.2 Global Filgrastim Injection Revenue Market Share by Company (2018-2023)
3.3 Global Filgrastim Injection Sale Price by Company
3.4 Key Manufacturers Filgrastim Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Filgrastim Injection Product Location Distribution
3.4.2 Players Filgrastim Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR FILGRASTIM INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Filgrastim Injection Market Size by Geographic Region (2018-2023)
4.1.1 Global Filgrastim Injection Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Filgrastim Injection Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Filgrastim Injection Market Size by Country/Region (2018-2023)
4.2.1 Global Filgrastim Injection Annual Sales by Country/Region (2018-2023)
4.2.2 Global Filgrastim Injection Annual Revenue by Country/Region (2018-2023)
4.3 Americas Filgrastim Injection Sales Growth
4.4 APAC Filgrastim Injection Sales Growth
4.5 Europe Filgrastim Injection Sales Growth
4.6 Middle East & Africa Filgrastim Injection Sales Growth
5 AMERICAS
5.1 Americas Filgrastim Injection Sales by Country
5.1.1 Americas Filgrastim Injection Sales by Country (2018-2023)
5.1.2 Americas Filgrastim Injection Revenue by Country (2018-2023)
5.2 Americas Filgrastim Injection Sales by Type
5.3 Americas Filgrastim Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Filgrastim Injection Sales by Region
6.1.1 APAC Filgrastim Injection Sales by Region (2018-2023)
6.1.2 APAC Filgrastim Injection Revenue by Region (2018-2023)
6.2 APAC Filgrastim Injection Sales by Type
6.3 APAC Filgrastim Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Filgrastim Injection by Country
7.1.1 Europe Filgrastim Injection Sales by Country (2018-2023)
7.1.2 Europe Filgrastim Injection Revenue by Country (2018-2023)
7.2 Europe Filgrastim Injection Sales by Type
7.3 Europe Filgrastim Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Filgrastim Injection by Country
8.1.1 Middle East & Africa Filgrastim Injection Sales by Country (2018-2023)
8.1.2 Middle East & Africa Filgrastim Injection Revenue by Country (2018-2023)
8.2 Middle East & Africa Filgrastim Injection Sales by Type
8.3 Middle East & Africa Filgrastim Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Filgrastim Injection
10.3 Manufacturing Process Analysis of Filgrastim Injection
10.4 Industry Chain Structure of Filgrastim Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Filgrastim Injection Distributors
11.3 Filgrastim Injection Customer
12 WORLD FORECAST REVIEW FOR FILGRASTIM INJECTION BY GEOGRAPHIC REGION
12.1 Global Filgrastim Injection Market Size Forecast by Region
12.1.1 Global Filgrastim Injection Forecast by Region (2024-2029)
12.1.2 Global Filgrastim Injection Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Filgrastim Injection Forecast by Type
12.7 Global Filgrastim Injection Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Accord Healthcare
13.1.1 Accord Healthcare Company Information
13.1.2 Accord Healthcare Filgrastim Injection Product Portfolios and Specifications
13.1.3 Accord Healthcare Filgrastim Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Accord Healthcare Main Business Overview
13.1.5 Accord Healthcare Latest Developments
13.2 Teva Pharmaceuticals
13.2.1 Teva Pharmaceuticals Company Information
13.2.2 Teva Pharmaceuticals Filgrastim Injection Product Portfolios and Specifications
13.2.3 Teva Pharmaceuticals Filgrastim Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Teva Pharmaceuticals Main Business Overview
13.2.5 Teva Pharmaceuticals Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Filgrastim Injection Product Portfolios and Specifications
13.3.3 Pfizer Filgrastim Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Amgen Inc
13.4.1 Amgen Inc Company Information
13.4.2 Amgen Inc Filgrastim Injection Product Portfolios and Specifications
13.4.3 Amgen Inc Filgrastim Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Amgen Inc Main Business Overview
13.4.5 Amgen Inc Latest Developments
13.5 Novartis AG
13.5.1 Novartis AG Company Information
13.5.2 Novartis AG Filgrastim Injection Product Portfolios and Specifications
13.5.3 Novartis AG Filgrastim Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Novartis AG Main Business Overview
13.5.5 Novartis AG Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Filgrastim Injection Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Filgrastim Injection by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Filgrastim Injection by Country/Region, 2018, 2022 & 2029
2.2 Filgrastim Injection Segment by Type
2.2.1 300mcg/mL (vial)
2.2.2 480mcg/1.6 mL (vial)
2.2.3 300mcg/0.5mL (Prefilled Syringe)
2.2.4 480mcg/0.8mL (Prefilled Syringe)
2.3 Filgrastim Injection Sales by Type
2.3.1 Global Filgrastim Injection Sales Market Share by Type (2018-2023)
2.3.2 Global Filgrastim Injection Revenue and Market Share by Type (2018-2023)
2.3.3 Global Filgrastim Injection Sale Price by Type (2018-2023)
2.4 Filgrastim Injection Segment by Application
2.4.1 Adult Use
2.4.2 Pediatric Use
2.4.3 Geriatric Use
2.5 Filgrastim Injection Sales by Application
2.5.1 Global Filgrastim Injection Sale Market Share by Application (2018-2023)
2.5.2 Global Filgrastim Injection Revenue and Market Share by Application (2018-2023)
2.5.3 Global Filgrastim Injection Sale Price by Application (2018-2023)
3 GLOBAL FILGRASTIM INJECTION BY COMPANY
3.1 Global Filgrastim Injection Breakdown Data by Company
3.1.1 Global Filgrastim Injection Annual Sales by Company (2018-2023)
3.1.2 Global Filgrastim Injection Sales Market Share by Company (2018-2023)
3.2 Global Filgrastim Injection Annual Revenue by Company (2018-2023)
3.2.1 Global Filgrastim Injection Revenue by Company (2018-2023)
3.2.2 Global Filgrastim Injection Revenue Market Share by Company (2018-2023)
3.3 Global Filgrastim Injection Sale Price by Company
3.4 Key Manufacturers Filgrastim Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Filgrastim Injection Product Location Distribution
3.4.2 Players Filgrastim Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR FILGRASTIM INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Filgrastim Injection Market Size by Geographic Region (2018-2023)
4.1.1 Global Filgrastim Injection Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Filgrastim Injection Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Filgrastim Injection Market Size by Country/Region (2018-2023)
4.2.1 Global Filgrastim Injection Annual Sales by Country/Region (2018-2023)
4.2.2 Global Filgrastim Injection Annual Revenue by Country/Region (2018-2023)
4.3 Americas Filgrastim Injection Sales Growth
4.4 APAC Filgrastim Injection Sales Growth
4.5 Europe Filgrastim Injection Sales Growth
4.6 Middle East & Africa Filgrastim Injection Sales Growth
5 AMERICAS
5.1 Americas Filgrastim Injection Sales by Country
5.1.1 Americas Filgrastim Injection Sales by Country (2018-2023)
5.1.2 Americas Filgrastim Injection Revenue by Country (2018-2023)
5.2 Americas Filgrastim Injection Sales by Type
5.3 Americas Filgrastim Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Filgrastim Injection Sales by Region
6.1.1 APAC Filgrastim Injection Sales by Region (2018-2023)
6.1.2 APAC Filgrastim Injection Revenue by Region (2018-2023)
6.2 APAC Filgrastim Injection Sales by Type
6.3 APAC Filgrastim Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Filgrastim Injection by Country
7.1.1 Europe Filgrastim Injection Sales by Country (2018-2023)
7.1.2 Europe Filgrastim Injection Revenue by Country (2018-2023)
7.2 Europe Filgrastim Injection Sales by Type
7.3 Europe Filgrastim Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Filgrastim Injection by Country
8.1.1 Middle East & Africa Filgrastim Injection Sales by Country (2018-2023)
8.1.2 Middle East & Africa Filgrastim Injection Revenue by Country (2018-2023)
8.2 Middle East & Africa Filgrastim Injection Sales by Type
8.3 Middle East & Africa Filgrastim Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Filgrastim Injection
10.3 Manufacturing Process Analysis of Filgrastim Injection
10.4 Industry Chain Structure of Filgrastim Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Filgrastim Injection Distributors
11.3 Filgrastim Injection Customer
12 WORLD FORECAST REVIEW FOR FILGRASTIM INJECTION BY GEOGRAPHIC REGION
12.1 Global Filgrastim Injection Market Size Forecast by Region
12.1.1 Global Filgrastim Injection Forecast by Region (2024-2029)
12.1.2 Global Filgrastim Injection Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Filgrastim Injection Forecast by Type
12.7 Global Filgrastim Injection Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Accord Healthcare
13.1.1 Accord Healthcare Company Information
13.1.2 Accord Healthcare Filgrastim Injection Product Portfolios and Specifications
13.1.3 Accord Healthcare Filgrastim Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Accord Healthcare Main Business Overview
13.1.5 Accord Healthcare Latest Developments
13.2 Teva Pharmaceuticals
13.2.1 Teva Pharmaceuticals Company Information
13.2.2 Teva Pharmaceuticals Filgrastim Injection Product Portfolios and Specifications
13.2.3 Teva Pharmaceuticals Filgrastim Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Teva Pharmaceuticals Main Business Overview
13.2.5 Teva Pharmaceuticals Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Filgrastim Injection Product Portfolios and Specifications
13.3.3 Pfizer Filgrastim Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Amgen Inc
13.4.1 Amgen Inc Company Information
13.4.2 Amgen Inc Filgrastim Injection Product Portfolios and Specifications
13.4.3 Amgen Inc Filgrastim Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Amgen Inc Main Business Overview
13.4.5 Amgen Inc Latest Developments
13.5 Novartis AG
13.5.1 Novartis AG Company Information
13.5.2 Novartis AG Filgrastim Injection Product Portfolios and Specifications
13.5.3 Novartis AG Filgrastim Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Novartis AG Main Business Overview
13.5.5 Novartis AG Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Filgrastim Injection Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Filgrastim Injection Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 300mcg/mL (vial)
Table 4. Major Players of 480mcg/1.6 mL (vial)
Table 5. Major Players of 300mcg/0.5mL (Prefilled Syringe)
Table 6. Major Players of 480mcg/0.8mL (Prefilled Syringe)
Table 7. Global Filgrastim Injection Sales by Type (2018-2023) & (KL)
Table 8. Global Filgrastim Injection Sales Market Share by Type (2018-2023)
Table 9. Global Filgrastim Injection Revenue by Type (2018-2023) & ($ million)
Table 10. Global Filgrastim Injection Revenue Market Share by Type (2018-2023)
Table 11. Global Filgrastim Injection Sale Price by Type (2018-2023) & (US$/L)
Table 12. Global Filgrastim Injection Sales by Application (2018-2023) & (KL)
Table 13. Global Filgrastim Injection Sales Market Share by Application (2018-2023)
Table 14. Global Filgrastim Injection Revenue by Application (2018-2023)
Table 15. Global Filgrastim Injection Revenue Market Share by Application (2018-2023)
Table 16. Global Filgrastim Injection Sale Price by Application (2018-2023) & (US$/L)
Table 17. Global Filgrastim Injection Sales by Company (2018-2023) & (KL)
Table 18. Global Filgrastim Injection Sales Market Share by Company (2018-2023)
Table 19. Global Filgrastim Injection Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Filgrastim Injection Revenue Market Share by Company (2018-2023)
Table 21. Global Filgrastim Injection Sale Price by Company (2018-2023) & (US$/L)
Table 22. Key Manufacturers Filgrastim Injection Producing Area Distribution and Sales Area
Table 23. Players Filgrastim Injection Products Offered
Table 24. Filgrastim Injection Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Filgrastim Injection Sales by Geographic Region (2018-2023) & (KL)
Table 28. Global Filgrastim Injection Sales Market Share Geographic Region (2018-2023)
Table 29. Global Filgrastim Injection Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Filgrastim Injection Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Filgrastim Injection Sales by Country/Region (2018-2023) & (KL)
Table 32. Global Filgrastim Injection Sales Market Share by Country/Region (2018-2023)
Table 33. Global Filgrastim Injection Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Filgrastim Injection Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Filgrastim Injection Sales by Country (2018-2023) & (KL)
Table 36. Americas Filgrastim Injection Sales Market Share by Country (2018-2023)
Table 37. Americas Filgrastim Injection Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Filgrastim Injection Revenue Market Share by Country (2018-2023)
Table 39. Americas Filgrastim Injection Sales by Type (2018-2023) & (KL)
Table 40. Americas Filgrastim Injection Sales by Application (2018-2023) & (KL)
Table 41. APAC Filgrastim Injection Sales by Region (2018-2023) & (KL)
Table 42. APAC Filgrastim Injection Sales Market Share by Region (2018-2023)
Table 43. APAC Filgrastim Injection Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Filgrastim Injection Revenue Market Share by Region (2018-2023)
Table 45. APAC Filgrastim Injection Sales by Type (2018-2023) & (KL)
Table 46. APAC Filgrastim Injection Sales by Application (2018-2023) & (KL)
Table 47. Europe Filgrastim Injection Sales by Country (2018-2023) & (KL)
Table 48. Europe Filgrastim Injection Sales Market Share by Country (2018-2023)
Table 49. Europe Filgrastim Injection Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Filgrastim Injection Revenue Market Share by Country (2018-2023)
Table 51. Europe Filgrastim Injection Sales by Type (2018-2023) & (KL)
Table 52. Europe Filgrastim Injection Sales by Application (2018-2023) & (KL)
Table 53. Middle East & Africa Filgrastim Injection Sales by Country (2018-2023) & (KL)
Table 54. Middle East & Africa Filgrastim Injection Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Filgrastim Injection Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Filgrastim Injection Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Filgrastim Injection Sales by Type (2018-2023) & (KL)
Table 58. Middle East & Africa Filgrastim Injection Sales by Application (2018-2023) & (KL)
Table 59. Key Market Drivers & Growth Opportunities of Filgrastim Injection
Table 60. Key Market Challenges & Risks of Filgrastim Injection
Table 61. Key Industry Trends of Filgrastim Injection
Table 62. Filgrastim Injection Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Filgrastim Injection Distributors List
Table 65. Filgrastim Injection Customer List
Table 66. Global Filgrastim Injection Sales Forecast by Region (2024-2029) & (KL)
Table 67. Global Filgrastim Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Filgrastim Injection Sales Forecast by Country (2024-2029) & (KL)
Table 69. Americas Filgrastim Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Filgrastim Injection Sales Forecast by Region (2024-2029) & (KL)
Table 71. APAC Filgrastim Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Filgrastim Injection Sales Forecast by Country (2024-2029) & (KL)
Table 73. Europe Filgrastim Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Filgrastim Injection Sales Forecast by Country (2024-2029) & (KL)
Table 75. Middle East & Africa Filgrastim Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Filgrastim Injection Sales Forecast by Type (2024-2029) & (KL)
Table 77. Global Filgrastim Injection Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Filgrastim Injection Sales Forecast by Application (2024-2029) & (KL)
Table 79. Global Filgrastim Injection Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Accord Healthcare Basic Information, Filgrastim Injection Manufacturing Base, Sales Area and Its Competitors
Table 81. Accord Healthcare Filgrastim Injection Product Portfolios and Specifications
Table 82. Accord Healthcare Filgrastim Injection Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 83. Accord Healthcare Main Business
Table 84. Accord Healthcare Latest Developments
Table 85. Teva Pharmaceuticals Basic Information, Filgrastim Injection Manufacturing Base, Sales Area and Its Competitors
Table 86. Teva Pharmaceuticals Filgrastim Injection Product Portfolios and Specifications
Table 87. Teva Pharmaceuticals Filgrastim Injection Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 88. Teva Pharmaceuticals Main Business
Table 89. Teva Pharmaceuticals Latest Developments
Table 90. Pfizer Basic Information, Filgrastim Injection Manufacturing Base, Sales Area and Its Competitors
Table 91. Pfizer Filgrastim Injection Product Portfolios and Specifications
Table 92. Pfizer Filgrastim Injection Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 93. Pfizer Main Business
Table 94. Pfizer Latest Developments
Table 95. Amgen Inc Basic Information, Filgrastim Injection Manufacturing Base, Sales Area and Its Competitors
Table 96. Amgen Inc Filgrastim Injection Product Portfolios and Specifications
Table 97. Amgen Inc Filgrastim Injection Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 98. Amgen Inc Main Business
Table 99. Amgen Inc Latest Developments
Table 100. Novartis AG Basic Information, Filgrastim Injection Manufacturing Base, Sales Area and Its Competitors
Table 101. Novartis AG Filgrastim Injection Product Portfolios and Specifications
Table 102. Novartis AG Filgrastim Injection Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 103. Novartis AG Main Business
Table 104. Novartis AG Latest Developments
Table 1. Filgrastim Injection Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Filgrastim Injection Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 300mcg/mL (vial)
Table 4. Major Players of 480mcg/1.6 mL (vial)
Table 5. Major Players of 300mcg/0.5mL (Prefilled Syringe)
Table 6. Major Players of 480mcg/0.8mL (Prefilled Syringe)
Table 7. Global Filgrastim Injection Sales by Type (2018-2023) & (KL)
Table 8. Global Filgrastim Injection Sales Market Share by Type (2018-2023)
Table 9. Global Filgrastim Injection Revenue by Type (2018-2023) & ($ million)
Table 10. Global Filgrastim Injection Revenue Market Share by Type (2018-2023)
Table 11. Global Filgrastim Injection Sale Price by Type (2018-2023) & (US$/L)
Table 12. Global Filgrastim Injection Sales by Application (2018-2023) & (KL)
Table 13. Global Filgrastim Injection Sales Market Share by Application (2018-2023)
Table 14. Global Filgrastim Injection Revenue by Application (2018-2023)
Table 15. Global Filgrastim Injection Revenue Market Share by Application (2018-2023)
Table 16. Global Filgrastim Injection Sale Price by Application (2018-2023) & (US$/L)
Table 17. Global Filgrastim Injection Sales by Company (2018-2023) & (KL)
Table 18. Global Filgrastim Injection Sales Market Share by Company (2018-2023)
Table 19. Global Filgrastim Injection Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Filgrastim Injection Revenue Market Share by Company (2018-2023)
Table 21. Global Filgrastim Injection Sale Price by Company (2018-2023) & (US$/L)
Table 22. Key Manufacturers Filgrastim Injection Producing Area Distribution and Sales Area
Table 23. Players Filgrastim Injection Products Offered
Table 24. Filgrastim Injection Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Filgrastim Injection Sales by Geographic Region (2018-2023) & (KL)
Table 28. Global Filgrastim Injection Sales Market Share Geographic Region (2018-2023)
Table 29. Global Filgrastim Injection Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Filgrastim Injection Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Filgrastim Injection Sales by Country/Region (2018-2023) & (KL)
Table 32. Global Filgrastim Injection Sales Market Share by Country/Region (2018-2023)
Table 33. Global Filgrastim Injection Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Filgrastim Injection Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Filgrastim Injection Sales by Country (2018-2023) & (KL)
Table 36. Americas Filgrastim Injection Sales Market Share by Country (2018-2023)
Table 37. Americas Filgrastim Injection Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Filgrastim Injection Revenue Market Share by Country (2018-2023)
Table 39. Americas Filgrastim Injection Sales by Type (2018-2023) & (KL)
Table 40. Americas Filgrastim Injection Sales by Application (2018-2023) & (KL)
Table 41. APAC Filgrastim Injection Sales by Region (2018-2023) & (KL)
Table 42. APAC Filgrastim Injection Sales Market Share by Region (2018-2023)
Table 43. APAC Filgrastim Injection Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Filgrastim Injection Revenue Market Share by Region (2018-2023)
Table 45. APAC Filgrastim Injection Sales by Type (2018-2023) & (KL)
Table 46. APAC Filgrastim Injection Sales by Application (2018-2023) & (KL)
Table 47. Europe Filgrastim Injection Sales by Country (2018-2023) & (KL)
Table 48. Europe Filgrastim Injection Sales Market Share by Country (2018-2023)
Table 49. Europe Filgrastim Injection Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Filgrastim Injection Revenue Market Share by Country (2018-2023)
Table 51. Europe Filgrastim Injection Sales by Type (2018-2023) & (KL)
Table 52. Europe Filgrastim Injection Sales by Application (2018-2023) & (KL)
Table 53. Middle East & Africa Filgrastim Injection Sales by Country (2018-2023) & (KL)
Table 54. Middle East & Africa Filgrastim Injection Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Filgrastim Injection Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Filgrastim Injection Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Filgrastim Injection Sales by Type (2018-2023) & (KL)
Table 58. Middle East & Africa Filgrastim Injection Sales by Application (2018-2023) & (KL)
Table 59. Key Market Drivers & Growth Opportunities of Filgrastim Injection
Table 60. Key Market Challenges & Risks of Filgrastim Injection
Table 61. Key Industry Trends of Filgrastim Injection
Table 62. Filgrastim Injection Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Filgrastim Injection Distributors List
Table 65. Filgrastim Injection Customer List
Table 66. Global Filgrastim Injection Sales Forecast by Region (2024-2029) & (KL)
Table 67. Global Filgrastim Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Filgrastim Injection Sales Forecast by Country (2024-2029) & (KL)
Table 69. Americas Filgrastim Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Filgrastim Injection Sales Forecast by Region (2024-2029) & (KL)
Table 71. APAC Filgrastim Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Filgrastim Injection Sales Forecast by Country (2024-2029) & (KL)
Table 73. Europe Filgrastim Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Filgrastim Injection Sales Forecast by Country (2024-2029) & (KL)
Table 75. Middle East & Africa Filgrastim Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Filgrastim Injection Sales Forecast by Type (2024-2029) & (KL)
Table 77. Global Filgrastim Injection Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Filgrastim Injection Sales Forecast by Application (2024-2029) & (KL)
Table 79. Global Filgrastim Injection Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Accord Healthcare Basic Information, Filgrastim Injection Manufacturing Base, Sales Area and Its Competitors
Table 81. Accord Healthcare Filgrastim Injection Product Portfolios and Specifications
Table 82. Accord Healthcare Filgrastim Injection Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 83. Accord Healthcare Main Business
Table 84. Accord Healthcare Latest Developments
Table 85. Teva Pharmaceuticals Basic Information, Filgrastim Injection Manufacturing Base, Sales Area and Its Competitors
Table 86. Teva Pharmaceuticals Filgrastim Injection Product Portfolios and Specifications
Table 87. Teva Pharmaceuticals Filgrastim Injection Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 88. Teva Pharmaceuticals Main Business
Table 89. Teva Pharmaceuticals Latest Developments
Table 90. Pfizer Basic Information, Filgrastim Injection Manufacturing Base, Sales Area and Its Competitors
Table 91. Pfizer Filgrastim Injection Product Portfolios and Specifications
Table 92. Pfizer Filgrastim Injection Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 93. Pfizer Main Business
Table 94. Pfizer Latest Developments
Table 95. Amgen Inc Basic Information, Filgrastim Injection Manufacturing Base, Sales Area and Its Competitors
Table 96. Amgen Inc Filgrastim Injection Product Portfolios and Specifications
Table 97. Amgen Inc Filgrastim Injection Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 98. Amgen Inc Main Business
Table 99. Amgen Inc Latest Developments
Table 100. Novartis AG Basic Information, Filgrastim Injection Manufacturing Base, Sales Area and Its Competitors
Table 101. Novartis AG Filgrastim Injection Product Portfolios and Specifications
Table 102. Novartis AG Filgrastim Injection Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 103. Novartis AG Main Business
Table 104. Novartis AG Latest Developments
LIST OF FIGURES
Figure 1. Picture of Filgrastim Injection
Figure 2. Filgrastim Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Filgrastim Injection Sales Growth Rate 2018-2029 (KL)
Figure 7. Global Filgrastim Injection Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Filgrastim Injection Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 300mcg/mL (vial)
Figure 10. Product Picture of 480mcg/1.6 mL (vial)
Figure 11. Product Picture of 300mcg/0.5mL (Prefilled Syringe)
Figure 12. Product Picture of 480mcg/0.8mL (Prefilled Syringe)
Figure 13. Global Filgrastim Injection Sales Market Share by Type in 2022
Figure 14. Global Filgrastim Injection Revenue Market Share by Type (2018-2023)
Figure 15. Filgrastim Injection Consumed in Adult Use
Figure 16. Global Filgrastim Injection Market: Adult Use (2018-2023) & (KL)
Figure 17. Filgrastim Injection Consumed in Pediatric Use
Figure 18. Global Filgrastim Injection Market: Pediatric Use (2018-2023) & (KL)
Figure 19. Filgrastim Injection Consumed in Geriatric Use
Figure 20. Global Filgrastim Injection Market: Geriatric Use (2018-2023) & (KL)
Figure 21. Global Filgrastim Injection Sales Market Share by Application (2022)
Figure 22. Global Filgrastim Injection Revenue Market Share by Application in 2022
Figure 23. Filgrastim Injection Sales Market by Company in 2022 (KL)
Figure 24. Global Filgrastim Injection Sales Market Share by Company in 2022
Figure 25. Filgrastim Injection Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Filgrastim Injection Revenue Market Share by Company in 2022
Figure 27. Global Filgrastim Injection Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Filgrastim Injection Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Filgrastim Injection Sales 2018-2023 (KL)
Figure 30. Americas Filgrastim Injection Revenue 2018-2023 ($ Millions)
Figure 31. APAC Filgrastim Injection Sales 2018-2023 (KL)
Figure 32. APAC Filgrastim Injection Revenue 2018-2023 ($ Millions)
Figure 33. Europe Filgrastim Injection Sales 2018-2023 (KL)
Figure 34. Europe Filgrastim Injection Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Filgrastim Injection Sales 2018-2023 (KL)
Figure 36. Middle East & Africa Filgrastim Injection Revenue 2018-2023 ($ Millions)
Figure 37. Americas Filgrastim Injection Sales Market Share by Country in 2022
Figure 38. Americas Filgrastim Injection Revenue Market Share by Country in 2022
Figure 39. Americas Filgrastim Injection Sales Market Share by Type (2018-2023)
Figure 40. Americas Filgrastim Injection Sales Market Share by Application (2018-2023)
Figure 41. United States Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Filgrastim Injection Sales Market Share by Region in 2022
Figure 46. APAC Filgrastim Injection Revenue Market Share by Regions in 2022
Figure 47. APAC Filgrastim Injection Sales Market Share by Type (2018-2023)
Figure 48. APAC Filgrastim Injection Sales Market Share by Application (2018-2023)
Figure 49. China Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Filgrastim Injection Sales Market Share by Country in 2022
Figure 57. Europe Filgrastim Injection Revenue Market Share by Country in 2022
Figure 58. Europe Filgrastim Injection Sales Market Share by Type (2018-2023)
Figure 59. Europe Filgrastim Injection Sales Market Share by Application (2018-2023)
Figure 60. Germany Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Filgrastim Injection Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Filgrastim Injection Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Filgrastim Injection Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Filgrastim Injection Sales Market Share by Application (2018-2023)
Figure 69. Egypt Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Filgrastim Injection in 2022
Figure 75. Manufacturing Process Analysis of Filgrastim Injection
Figure 76. Industry Chain Structure of Filgrastim Injection
Figure 77. Channels of Distribution
Figure 78. Global Filgrastim Injection Sales Market Forecast by Region (2024-2029)
Figure 79. Global Filgrastim Injection Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Filgrastim Injection Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Filgrastim Injection Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Filgrastim Injection Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Filgrastim Injection Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Filgrastim Injection
Figure 2. Filgrastim Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Filgrastim Injection Sales Growth Rate 2018-2029 (KL)
Figure 7. Global Filgrastim Injection Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Filgrastim Injection Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 300mcg/mL (vial)
Figure 10. Product Picture of 480mcg/1.6 mL (vial)
Figure 11. Product Picture of 300mcg/0.5mL (Prefilled Syringe)
Figure 12. Product Picture of 480mcg/0.8mL (Prefilled Syringe)
Figure 13. Global Filgrastim Injection Sales Market Share by Type in 2022
Figure 14. Global Filgrastim Injection Revenue Market Share by Type (2018-2023)
Figure 15. Filgrastim Injection Consumed in Adult Use
Figure 16. Global Filgrastim Injection Market: Adult Use (2018-2023) & (KL)
Figure 17. Filgrastim Injection Consumed in Pediatric Use
Figure 18. Global Filgrastim Injection Market: Pediatric Use (2018-2023) & (KL)
Figure 19. Filgrastim Injection Consumed in Geriatric Use
Figure 20. Global Filgrastim Injection Market: Geriatric Use (2018-2023) & (KL)
Figure 21. Global Filgrastim Injection Sales Market Share by Application (2022)
Figure 22. Global Filgrastim Injection Revenue Market Share by Application in 2022
Figure 23. Filgrastim Injection Sales Market by Company in 2022 (KL)
Figure 24. Global Filgrastim Injection Sales Market Share by Company in 2022
Figure 25. Filgrastim Injection Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Filgrastim Injection Revenue Market Share by Company in 2022
Figure 27. Global Filgrastim Injection Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Filgrastim Injection Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Filgrastim Injection Sales 2018-2023 (KL)
Figure 30. Americas Filgrastim Injection Revenue 2018-2023 ($ Millions)
Figure 31. APAC Filgrastim Injection Sales 2018-2023 (KL)
Figure 32. APAC Filgrastim Injection Revenue 2018-2023 ($ Millions)
Figure 33. Europe Filgrastim Injection Sales 2018-2023 (KL)
Figure 34. Europe Filgrastim Injection Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Filgrastim Injection Sales 2018-2023 (KL)
Figure 36. Middle East & Africa Filgrastim Injection Revenue 2018-2023 ($ Millions)
Figure 37. Americas Filgrastim Injection Sales Market Share by Country in 2022
Figure 38. Americas Filgrastim Injection Revenue Market Share by Country in 2022
Figure 39. Americas Filgrastim Injection Sales Market Share by Type (2018-2023)
Figure 40. Americas Filgrastim Injection Sales Market Share by Application (2018-2023)
Figure 41. United States Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Filgrastim Injection Sales Market Share by Region in 2022
Figure 46. APAC Filgrastim Injection Revenue Market Share by Regions in 2022
Figure 47. APAC Filgrastim Injection Sales Market Share by Type (2018-2023)
Figure 48. APAC Filgrastim Injection Sales Market Share by Application (2018-2023)
Figure 49. China Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Filgrastim Injection Sales Market Share by Country in 2022
Figure 57. Europe Filgrastim Injection Revenue Market Share by Country in 2022
Figure 58. Europe Filgrastim Injection Sales Market Share by Type (2018-2023)
Figure 59. Europe Filgrastim Injection Sales Market Share by Application (2018-2023)
Figure 60. Germany Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Filgrastim Injection Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Filgrastim Injection Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Filgrastim Injection Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Filgrastim Injection Sales Market Share by Application (2018-2023)
Figure 69. Egypt Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Filgrastim Injection Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Filgrastim Injection in 2022
Figure 75. Manufacturing Process Analysis of Filgrastim Injection
Figure 76. Industry Chain Structure of Filgrastim Injection
Figure 77. Channels of Distribution
Figure 78. Global Filgrastim Injection Sales Market Forecast by Region (2024-2029)
Figure 79. Global Filgrastim Injection Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Filgrastim Injection Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Filgrastim Injection Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Filgrastim Injection Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Filgrastim Injection Revenue Market Share Forecast by Application (2024-2029)
